DOCSLIB.ORG

Hereditary Etiologies of Hypomagnesemia Amir Said Alizadeh Naderi* and Robert F Reilly Jr

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hereditary Etiologies of Hypomagnesemia Amir Said Alizadeh Naderi* and Robert F Reilly Jr REVIEW REVIEW www.nature.com/clinicalpractice/neph Hereditary etiologies of hypomagnesemia Amir Said Alizadeh Naderi* and Robert F Reilly Jr SUMMARY Continuing Medical Education online Medscape, LLC is pleased to provide online continuing Magnesium ions are essential to all living cells. As the second most medical education (CME) for this journal article, allowing abundant intracellular cation, magnesium has a crucial role in clinicians the opportunity to earn CME credit. Medscape, fundamental metabolic processes such as DNA and protein synthesis, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME oxidative phosphorylation, enzyme function, ion channel regulation, and for physicians. Medscape, LLC designates this educa- neuromuscular excitability. After presenting an overview of magnesium tional activity for a maximum of 1.0 AMA PRA Category 1 homeostasis, we review the etiologies of hypomagnesemia, with an Credits™. Physicians should only claim credit commen- emphasis on hereditary causes. surate with the extent of their participation in the activity. All other clinicians completing this activity will KEYWORDS Bartter syndrome, Gitelman syndrome, hypomagnesemia, be issued a certificate of participation. To receive credit, 2+ renal Mg handling please go to http://www.medscape.com/cme/ncp and complete the post-test. ReVieW CRITERia A literature search was performed in the PubMed and Ovid databases Learning objectives using the following search terms: “hypomagnesemia”, “hereditary causes”, Upon completion of this activity, participants should be “hypomagnesemia with secondary hypocalcemia”, “TRPM6 mutation”, “Bartter able to: syndrome”, “Gitelman syndrome”, “familial hypomagnesemia with hypercalciuria 1 Identify dietary sources that are high in magnesium. and nephrocalcinosis”, “paracellin-1”, “autosomal dominant hypomagnesemia 2 Describe the recommended daily intake of with hypocalciuria”, “isolated recessive hypomagnesemia”, “autosomal dominant magnesium for adult women and men. hypocalcemia”, and “Ca2+/Mg2+-sensing receptor activating mutations”. 3 Describe the most common clinical presentations of hypomagnesemia. CME 4 Identify the most likely concurrent electrolyte, endo- crine, and metabolic abnormalities occurring with hypomagnesemia. 5 Describe the inheritance patterns of hereditary causes of hypomagnesemia. Competing interests The authors declared no competing interests. Désirée Lie, the CME questions author, declared no relevant financial relationships. INTRODUCTION Magnesium is found in a wide variety of foods, and at particularly high levels in unrefined whole grain cereals, green leafy vegetables, nuts, seeds, peas and beans. A balanced Western diet contains ASA Naderi is a Senior Resident in the Department of Internal Medicine, approximately 360 mg of magnesium per day; and RF Reilly Jr is Professor of Medicine, Fredric L Coe Professor of only about 120 mg of this is absorbed in the Nephrolithiasis Research and Chief of the Division of Nephrology, VA North intestine. Gastrointestinal magnesium absorp- Texas Heath Care System, both at The University of Texas Southwestern tion is mediated by a saturable transcellular Medical Center at Dallas, Dallas, TX, USA. active pathway, as well as by nonsaturable para- cellular passive transport.1 The intestine secretes Correspondence *Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, about 40 mg of magnesium per day and about 5323 Harry Hines Boulevard, Dallas, TX 75390-8837, USA 20 mg is absorbed in the large bowel. Magnesium [email protected] homeostasis is maintained by urinary excretion of approximately 100 mg/day. Regulation of renal Received 4 July 2007 Accepted 20 September 2007 www.nature.com/clinicalpractice magnesium excretion maintains physiologic doi:10.1038/ncpneph0680 serum concentrations at between 0.75 and 80 NATURE CLINICAL PRACTICE NEPHROLOGY FEBRUAry 2008 Vol 4 no 2 NNature.indtature.indt 1 228/11/078/11/07 99:46:50:46:50 aamm REVIEW REVIEW www.nature.com/clinicalpractice/neph 0.95 mmol/l (1.8–2.3 mg/dl) in healthy humans. Apical Basolateral The recommended dietary intake of magnesium, membrane membrane which reflects the amount that meets the needs of Paracellin-1 (claudin-16) almost all (98%) healthy individuals, is 320 mg/day Ca2+, Mg2+ (13.3 mmol/day) for adult females and 420 mg/day (17.5 mmol/day) for adult males.2 Claudin-19 Na+/K+-ATPase ReNal maGNESIUM HANDliNG Na+ 3Na+ – The kidney is the major regulator of total body Tubular lumen 2CI K+ 2K+ magnesium homeostasis. Several mechanisms enable the kidney to regulate and maintain NKCC2 2+ 2+ serum magnesium concentration within a Ca /Mg - sensing receptor narrow range. In the setting of hypomagnesemia, the kidney decreases magnesium excretion to as K+ little as 0.5% of the filtered load. Conversely, – in the setting of hypermagnesemia, up to 80% CI of the filtered load can be excreted.3 A propor- Barttin tion of circulating magnesium is protein bound, ROMK CLCKA and CLCKB such that only 70% of total plasma magnesium Figure 1 Magnesium transport in the thick ascending limb of the loop of Henle is ultrafilterable.4 In adults, a small fraction of is passive and paracellular, perhaps mediated by paracellin-1 (claudin-16) filtered magnesium is reabsorbed in the proximal and claudin-19. The lumen-positive electrical gradient is the driving force for paracellular magnesium transport and is dependent on potassium exit tubule. In contrast to most other ions, which are via ROMK. Sodium entry and exit are mediated via the furosemide-sensitive primarily reabsorbed in the proximal tubule, NKCC2 and the Na+/K+-ATPase, respectively. The Ca+/Mg2+-sensing receptor the thick ascending limb of the loop of Henle expressed in the basolateral membrane is an important regulator of ROMK and is the main site of magnesium reabsorption NKCC2. Abbreviations: CLCKA and CLCKB, renal chloride channels; NKCC2, + + – (Figure 1). The Ca2+/Mg2+-sensing receptor Na –K –2Cl cotransporter; ROMK, renal outer medulla potassium channel. (CASR), a member of the G-protein-coupled receptor family, is an important regulator of magnesium homeostasis.5 This receptor is located in the basolateral membrane of thick receptor potential family of cation channels, ascending limb cells and in the distal convo- is expressed in the apical membrane of distal luted tubule, as well as in cells of the parathyroid convoluted tubule and brush-border membrane glands that secrete parathyroid hormone (PTH). of absorptive cells in duodenum; TRPM6 has In hypomagnesemic or hypocalcemic states, the been characterized as a magnesium-permeable rates of calcium and magnesium reabsorption channel.10,11 About 10% of filtered magnesium in the loop of Henle are increased via CASR- is reabsorbed in the distal convoluted tubule mediated stimulation of the Na+–K+–2Cl– by transcellular active transport (Figure 2). As cotransporter and the apical ROMK (renal there is little magnesium reabsorption beyond outer medulla potassium) channel.6 By contrast, the distal tubule, this segment ultimately hypermagnesemia and hypercalcemia inhibit regulates urinary magnesium excretion.12 Na+–K+–2Cl– cotransport and activity of the TRPM7 is a recently discovered magnesium- ROMK channel. permeable ion channel, the role of which in Magnesium transport in the thick ascending cellular magnesium homeostasis is currently limb is mainly passive in nature, occurring via being investigated.13 a paracellular pathway driven by the electrical gradient that results from potassium exit across CliNical maNIFESTATIONS the apical membrane through ROMK chan- OF HYPOmaGNESemia nels.7,8 Paracellin-1 (claudin-16) is expressed Hypomagnesemia is defined as a serum magne- in tight junctions of the thick ascending limb sium concentration of less than 0.74 mmol/l of the loop of Henle and is required for selective (<1.8 mg/dl). Early symptoms of hypo- paracellular magnesium conductance.9 A trans- magnesemia are nonspecific and include epithelial magnesium transport mechanism lethargy and weakness. More pronounced in intestine and kidney was identified a few hypomagnesemia presents with symptoms of years ago. TRPM6, a member of the transient increased neuromuscular excitability such as ncpneph_2007_134f1.eps FEBRUAry 2008 Vol 4 no 2 NADERI AND REILLY NATURE CLINICAL PRACTICE NEPHROLOGY 81 NNature.indtature.indt 1 228/11/078/11/07 99:46:50:46:50 aamm REVIEW REVIEW www.nature.com/clinicalpractice/neph Apical Basolateral Hypocalcemia, which is common in patients membrane membrane with severe hypomagnesemia (<1.2 mg/dl [<0.5 mmol/l]), is attributable to several patho- Na+/K+-ATPase physiologic processes. In many individuals the concentration of PTH is inappropriately low, NCCT 3Na+ and bone resistance to the effects of PTH is γ a well-documented phenomenon.16,17 The Na+ 2K+ Tubular lumen kidney is also refractory to PTH, as mani- 2+ ? CI– Mg fested by impaired cyclic AMP generation and CLCKB phosphate reabsorption.18 Administration CI– of magnesium immediately increases PTH Barttin EGF receptor concentration, probably as a result of release of EGF preformed PTH from the parathyroid gland; Mg2+ nevertheless, it can take several days for the serum calcium concentration to normalize, presumably because end-organ resistance is slow to resolve. TRPM6 Mutated pro-EGF Abnormalities of vitamin D metabolism Figure 2 The distal convoluted tubule reabsorbs Mg2+ via an active transcellular route. Mg2+ entry is via the TRPM6 channel.
Load more

Recommended publications
  • Structural Basis for Disruption of Claudin Assembly in Tight Junctions
    www.nature.com/scientificreports OPEN Structural basis for disruption of claudin assembly in tight junctions by an enterotoxin Received: 11 May 2016 Takehiro Shinoda1,2, Naoko Shinya1,2, Kaori Ito1,2, Noboru Ohsawa1,2, Takaho Terada1,3, Accepted: 01 September 2016 Kunio Hirata4, Yoshiaki Kawano4, Masaki Yamamoto4, Tomomi Kimura-Someya1,2, Published: 20 September 2016 Shigeyuki Yokoyama1,3 & Mikako Shirouzu1,2 The food-poisoning bacterium Clostridium perfringens produces an enterotoxin (~35 kDa) that specifically targets human claudin-4, among the 26 human claudin proteins, and causes diarrhea by fluid accumulation in the intestinal cavity. The C-terminal domain of the Clostridium perfringens enterotoxin (C-CPE, ~15 kDa) binds tightly to claudin-4, and disrupts the intestinal tight junction barriers. In this study, we determined the 3.5-Å resolution crystal structure of the cell-free synthesized human claudin- 4•C-CPE complex, which is significantly different from the structure of the off-target complex of an engineered C-CPE with mouse claudin-19. The claudin-4•C-CPE complex structure demonstrated the mechanism underlying claudin assembly disruption. A comparison of the present C-CPE-bound structure of claudin-4 with the enterotoxin-free claudin-15 structure revealed sophisticated C-CPE- induced conformation changes of the extracellular segments, induced on the foundation of the rigid four-transmembrane-helix bundle structure. These conformation changes provide a mechanistic model for the disruption of the lateral assembly of claudin molecules. Furthermore, the present novel structural mechanism for selecting a specific member of the claudin family can be used as the foundation to develop novel medically important technologies to selectively regulate the tight junctions formed by claudin family members in different organs.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Mutations in the Tight-Junction Gene Claudin 19 (CLDN19) Are Associated with Renal Magnesium Wasting, Renal Failure, and Severe Ocular Involvement
    Mutations in the Tight-Junction Gene Claudin 19 (CLDN19) Are Associated with Renal Magnesium Wasting, Renal Failure, and Severe Ocular Involvement Martin Konrad, Andre´ Schaller, Dominik Seelow, Amit V. Pandey, Siegfried Waldegger, Annegret Lesslauer, Helga Vitzthum, Yoshiro Suzuki, John M. Luk, Christian Becker, Karl P. Schlingmann, Marcel Schmid, Juan Rodriguez-Soriano, Gema Ariceta, Francisco Cano, Ricardo Enriquez, Harald Ju¨ppner, Sevcan A. Bakkaloglu, Matthias A. Hediger, Sabina Gallati, Stephan C. F. Neuhauss, Peter Nu¨rnberg, and Stefanie Weber Claudins are major components of tight junctions and contribute to the epithelial-barrier function by restricting free diffusion of solutes through the paracellular pathway. We have mapped a new locus for recessive renal magnesium loss on chromosome 1p34.2 and have identified mutations in CLDN19, a member of the claudin multigene family, in patients affected by hypomagnesemia, renal failure, and severe ocular abnormalities. CLDN19 encodes the tight-junction protein claudin-19, and we demonstrate high expression of CLDN19 in renal tubules and the retina. The identified mutations interfere severely with either cell-membrane trafficking or the assembly of the claudin-19 protein. The identification of CLDN19 mutations in patients with chronic renal failure and severe visual impairment supports the fundamental role of claudin-19 for normal renal tubular function and undisturbed organization and development of the retina. Tight junctions constitute cell-cell contacts by forming cir- calcium reabsorption
    [Show full text]
  • Single Cell Transcriptional and Chromatin Accessibility Profiling Redefine Cellular Heterogeneity in the Adult Human Kidney
    ARTICLE https://doi.org/10.1038/s41467-021-22368-w OPEN Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney Yoshiharu Muto 1,7, Parker C. Wilson 2,7, Nicolas Ledru 1, Haojia Wu1, Henrik Dimke 3,4, ✉ Sushrut S. Waikar 5 & Benjamin D. Humphreys 1,6 1234567890():,; The integration of single cell transcriptome and chromatin accessibility datasets enables a deeper understanding of cell heterogeneity. We performed single nucleus ATAC (snATAC- seq) and RNA (snRNA-seq) sequencing to generate paired, cell-type-specific chromatin accessibility and transcriptional profiles of the adult human kidney. We demonstrate that snATAC-seq is comparable to snRNA-seq in the assignment of cell identity and can further refine our understanding of functional heterogeneity in the nephron. The majority of differ- entially accessible chromatin regions are localized to promoters and a significant proportion are closely associated with differentially expressed genes. Cell-type-specific enrichment of transcription factor binding motifs implicates the activation of NF-κB that promotes VCAM1 expression and drives transition between a subpopulation of proximal tubule epithelial cells. Our multi-omics approach improves the ability to detect unique cell states within the kidney and redefines cellular heterogeneity in the proximal tubule and thick ascending limb. 1 Division of Nephrology, Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA. 2 Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO, USA. 3 Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark. 4 Department of Nephrology, Odense University Hospital, Odense, Denmark.
    [Show full text]
  • Differences in Gene Expression Profiles and Carcinogenesis Pathways Involved in Cisplatin Resistance of Four Types of Cancer
    596 ONCOLOGY REPORTS 30: 596-614, 2013 Differences in gene expression profiles and carcinogenesis pathways involved in cisplatin resistance of four types of cancer YONG YANG1,2, HUI LI1,2, SHENGCAI HOU1,2, BIN HU1,2, JIE LIU1,3 and JUN WANG1,3 1Beijing Key Laboratory of Respiratory and Pulmonary Circulation, Capital Medical University, Beijing 100069; 2Department of Thoracic Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020; 3Department of Physiology, Capital Medical University, Beijing 100069, P.R. China Received December 23, 2012; Accepted March 4, 2013 DOI: 10.3892/or.2013.2514 Abstract. Cisplatin-based chemotherapy is the standard Introduction therapy used for the treatment of several types of cancer. However, its efficacy is largely limited by the acquired drug Cisplatin is primarily effective through DNA damage and is resistance. To date, little is known about the RNA expression widely used for the treatment of several types of cancer, such changes in cisplatin-resistant cancers. Identification of the as testicular, lung and ovarian cancer. However, the ability RNAs related to cisplatin resistance may provide specific of cancer cells to become resistant to cisplatin remains a insight into cancer therapy. In the present study, expression significant impediment to successful chemotherapy. Although profiling of 7 cancer cell lines was performed using oligo- previous studies have identified numerous mechanisms in nucleotide microarray analysis data obtained from the GEO cisplatin resistance, it remains a major problem that severely database. Bioinformatic analyses such as the Gene Ontology limits the usefulness of this chemotherapeutic agent. Therefore, (GO) and KEGG pathway were used to identify genes and it is crucial to examine more elaborate mechanisms of cisplatin pathways specifically associated with cisplatin resistance.
    [Show full text]
  • CLDN19 Monoclonal Antibody (M02), Clone 2F2
    CLDN19 monoclonal antibody (M02), clone 2F2 Catalog # : H00149461-M02 規格 : [ 100 ug ] List All Specification Application Image Product Mouse monoclonal antibody raised against a full-length recombinant Western Blot (Recombinant protein) Description: CLDN19. Sandwich ELISA (Recombinant Immunogen: CLDN19 (AAH30524, 1 a.a. ~ 211 a.a) full-length recombinant protein protein) with GST tag. MW of the GST tag alone is 26 KDa. Sequence: MANSGLQLLGYFLALGGWVGIIASTALPQWKQSSYAGDAIITAVGLYEGL WMSCASQSTGQVQCKLYDSLLALDGHIQSARALMVVAVLLGFVAMVLS VVGMKCTRVGDSNPIAKGRVAIAGGALFILAGLCTLTAVSWYATLVTQEF FNPSTPVNARYEFGPALFVGWASAGLAVLGGSFLCCTCPEPERPNSSP QPYRPGPSAAAREYV enlarge Host: Mouse ELISA Reactivity: Human Isotype: IgG2a Kappa Quality Control Antibody Reactive Against Recombinant Protein. Testing: Western Blot detection against Immunogen (48.95 KDa) . Storage Buffer: In 1x PBS, pH 7.4 Storage Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. Instruction: MSDS: Download Datasheet: Download Applications Western Blot (Recombinant protein) Protocol Download Sandwich ELISA (Recombinant protein) Page 1 of 2 2018/11/27 Detection limit for recombinant GST tagged CLDN19 is 0.1 ng/ml as a capture antibody. Protocol Download ELISA Gene Information Entrez GeneID: 149461 GeneBank BC030524 Accession#: Protein AAH30524 Accession#: Gene Name: CLDN19 Gene Alias: - Gene claudin 19 Description: Omim ID: 248190, 610036 Gene Ontology: Hyperlink Gene Summary: The product of this gene belongs to the claudin family. It plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. Defects in this gene are the cause of hypomagnesemia renal with ocular involvement (HOMGO). HOMGO is a progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus.
    [Show full text]
  • Notate Human RPE-Specific Gene Expression
    UvA-DARE (Digital Academic Repository) Function and pathology of the human retinal pigment epithelium Booij, J.C. Publication date 2010 Link to publication Citation for published version (APA): Booij, J. C. (2010). Function and pathology of the human retinal pigment epithelium. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:25 Sep 2021 A new strategy to identify and an- notate human RPE-specific gene expression 3 Judith C Booij, Jacoline B ten Brink, Sigrid MA Swagemakers, Annemieke JMH Verkerk, Anke HW Essing, Peter J van der Spek, Arthur AB Bergen. PlosOne 2010, 5(3) e9341 Chapter 3 Abstract Background: The aim of the study was to identify and functionally annotate cell type-spe- cific gene expression in the human retinal pigment epithelium (RPE), a key tissue involved in age-related macular degeneration and retinitis pigmentosa.
    [Show full text]
  • In-Depth Bioinformatic Study of the CLDN16 Gene and Protein: Prediction of Subcellular Localization to Mitochondria
    medicina Article In-Depth Bioinformatic Study of the CLDN16 Gene and Protein: Prediction of Subcellular Localization to Mitochondria Erasmia Rouka 1,*, Vassilios Liakopoulos 2 , Konstantinos I. Gourgoulianis 3, Chrissi Hatzoglou 4 and Sotirios G. Zarogiannis 4 1 Department of Transfusion Medicine, University Hospital of Larissa, Biopolis, 41334 Larissa, Greece 2 Peritoneal Dialysis Unit, 1st Department of Medicine, Ahepa Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece 3 Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, 41334 Larissa, Greece 4 Department of Physiology, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece * Correspondence: [email protected]; Tel.: +30-6977-690-694 Received: 16 April 2019; Accepted: 22 July 2019; Published: 26 July 2019 Abstract: Background and Objectives: The defects in the CLDN16 gene are a cause of primary hypomagnesemia (FHHNC), which is characterized by massive renal magnesium wasting, resulting in nephrocalcinosis and renal failure. The mutations occur throughout the gene’s coding region and can impact on intracellular trafficking of the protein or its paracellular pore forming function. To gain more understanding about the mechanisms by which CLDN16 mutations can induce FHHNC, we performed an in-depth computational analysis of the CLDN16 gene and protein, focusing specifically on the prediction of the latter’s subcellular localization. Materials and Methods: The complete nucleotide or amino acid sequence of CLDN16 in FASTA format was entered and processed in 14 databases. Results: One CpG island was identified. Twenty five promoters/enhancers were predicted. The CLDN16 interactome was found to consist of 20 genes, mainly involved in kidney diseases. No signal peptide cleavage site was identified.
    [Show full text]
  • Gene Modules Associated with Human Diseases Revealed by Network
    bioRxiv preprint doi: https://doi.org/10.1101/598151; this version posted June 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Gene modules associated with human diseases revealed by network analysis Shisong Ma1,2*, Jiazhen Gong1†, Wanzhu Zuo1†, Haiying Geng1, Yu Zhang1, Meng Wang1, Ershang Han1, Jing Peng1, Yuzhou Wang1, Yifan Wang1, Yanyan Chen1 1. Hefei National Laboratory for Physical Sciences at the Microscale, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China 2. School of Data Science, University of Science and Technology of China, Hefei, Anhui 230027, China * To whom correspondence should be addressed. Email: [email protected] † These authors contribute equally. 1 bioRxiv preprint doi: https://doi.org/10.1101/598151; this version posted June 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT Despite many genes associated with human diseases have been identified, disease mechanisms often remain elusive due to the lack of understanding how disease genes are connected functionally at pathways level. Within biological networks, disease genes likely map to modules whose identification facilitates etiology studies but remains challenging. We describe a systematic approach to identify disease-associated gene modules.
    [Show full text]
  • Disease-Associated Mutations of Claudin-19 Disrupt Retinal Neurogenesis and Visual Function
    ARTICLE https://doi.org/10.1038/s42003-019-0355-0 OPEN Disease-associated mutations of claudin-19 disrupt retinal neurogenesis and visual function Shao-Bin Wang1,2,4, Tao Xu1,2,3, Shaomin Peng3, Deepti Singh1,2,5, Maryam Ghiassi-Nejad1,2, Ron A. Adelman2 & Lawrence J. Rizzolo 1,2 1234567890():,; Mutations of claudin-19 cause Familial Hypomagnesaemia and Hypercalciuria, Nephrocalci- nosis with Ocular Involvement. To study the ocular disease without the complications of the kidney disease, naturally occurring point mutations of human CLDN19 were recreated in human induced pluripotent cells or overexpressed in the retinae of newborn mice. In human induced pluripotent cells, we show that the mutation affects retinal neurogenesis and maturation of retinal pigment epithelium (RPE). In mice, the mutations diminish the P1 wave of the electroretinogram, activate apoptosis in the outer nuclear layer, and alter the mor- phology of bipolar cells. If mice are given 9-cis-retinal to counter the loss of retinal isomerase, the P1 wave is partially restored. The ARPE19 cell line fails to express claudin-19. Exogenous expression of wild type, but not mutant claudin-19, increases the expression of RPE signature genes. Mutated claudin-19 affects multiple stages of RPE and retinal differentiation through its effects on multiple functions of the RPE. 1 Department of Surgery, Yale University, PO Box 208062, New Haven, CT, USA. 2 Department of Ophthalmology, Yale University, 40 Temple Street, New Haven, CT, USA. 3 Aier School of Ophthalmology, Central South University, 198 Furong Middle Ave Section 2, Tianxin District, Changsha, China. 4Present address: Center for Advanced Vision Science, Department of Ophthalmology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
    [Show full text]
  • Primepcr™Assay Validation Report
    PrimePCR™Assay Validation Report Gene Information Gene Name claudin 19 Gene Symbol Cldn19 Organism Mouse Gene Summary This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets and also play critical roles in maintaining cell polarity and signal transductions. siRNA knockdown of this gene in mice develops the FHHNC (familial hypomagnesemia with hypercalciuria and nephrocalcinosis) symptoms of chronic renal wasting of magnesium and calcium together with defective renal salt handling. The protein encoded by this gene interacts with another family member Claudin 16 and their interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. This protein is a constituent of tight junctions in the Schwann cells of peripheral myelinated nerves and the gene deficiency affects the nerve conduction of peripheral myelinated fibers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Gene Aliases Not Available RefSeq Accession No. NC_000070.6, NT_039264.7 UniGene ID Mm.130701 Ensembl Gene ID ENSMUSG00000066058 Entrez Gene ID 242653 Assay Information Unique Assay ID qMmuCIP0035726 Assay Type Probe - Validation information is for the primer pair using SYBR® Green detection Detected Coding Transcript(s) ENSMUST00000084309,
    [Show full text]
  • Mouse Models of Human Claudin-Associated Disorders: Benefits and Limitations
    International Journal of Molecular Sciences Review Mouse Models of Human Claudin-Associated Disorders: Benefits and Limitations Murat Seker 1 , Cármen Fernández-Rodríguez 2, Luis Alfonso Martínez-Cruz 2 and Dominik Müller 1,* 1 Department of Pediatric Gastroenterology, Nephrology and Metabolism, Charité—Universitätsmedizin Berlin, Charité, 13353 Berlin, Germany; [email protected] 2 ClC BioGUNE, Bizkaia Science and Technology Park, 801A, 48160 Derio, Spain; [email protected] (C.F.-R.); [email protected] (L.A.M.-C.) * Correspondence: [email protected] Received: 15 October 2019; Accepted: 2 November 2019; Published: 5 November 2019 Abstract: In higher organisms, epithelia separate compartments in order to guarantee their proper function. Such structures are able to seal but also to allow substances to pass. Within the paracellular pathway, a supramolecular structure, the tight junction transport is largely controlled by the temporospatial regulation of its major protein family called claudins. Besides the fact that the expression of claudins has been identified in different forms of human diseases like cancer, clearly defined mutations in the corresponding claudin genes have been shown to cause distinct human disorders. Such disorders comprise the skin and its adjacent structures, liver, kidney, the inner ear, and the eye. From the phenotype analysis, it has also become clear that different claudins can cause a complex phenotype when expressed in different organs. To gain deeper insights into the physiology and pathophysiology of claudin-associated disorders, several mouse models have been generated. In order to model human disorders in detail, they have been designed either as full knockouts, knock-downs or knock-ins by a variety of techniques.
    [Show full text]